Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	2.54	1.71	1.16	0.44	0.02
Revenue Growth (YoY)	48.80%	47.06%	165.64%	2460.31%	-
Gross Profit	2.54	1.71	1.16	0.44	0.02
Selling, General & Admin	3.56	3.65	3.74	3.4	4.73
Research & Development	3.49	4.77	3.16	1.73	4.89
Other Operating Expenses	0	0	0	9.24	3.28
Operating Expenses	7.06	8.42	6.91	14.37	12.9
Operating Income	-4.52	-6.72	-5.75	-13.94	-12.89
Other Expense / Income	-0.38	-0.17	-0.1	-0.13	-0.11
Pretax Income	-4.13	-6.55	-5.65	-13.81	-12.78
Income Tax	0	0	0	-2.92	0
Net Income	-4.13	-6.55	-5.65	-10.89	-12.78
Preferred Dividends	0	0	0	0	5.28
Net Income Common	-4.13	-6.55	-5.65	-10.89	-18.06
Shares Outstanding (Basic)	2	1	1	1	0
Shares Outstanding (Diluted)	2	1	1	1	0
Shares Change	7.44%	38.38%	60.81%	124.10%	277.30%
EPS (Basic)	-2.71	-4.61	-5.50	-17.00	-63.30
EPS (Diluted)	-2.71	-4.61	-5.50	-17.00	-63.30
Free Cash Flow	-4.11	-4.65	-4.74	-4.27	-6.4
Free Cash Flow Per Share	-2.69	-3.27	-4.61	-6.67	-22.43
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-177.79%	-393.57%	-495.12%	-3189.82%	-75511.71%
Profit Margin	-162.78%	-383.87%	-486.36%	-2493.11%	-105820.95%
Free Cash Flow Margin	-161.98%	-272.23%	-408.21%	-976.60%	-37486.25%
EBITDA	-4.13	-6.53	-5.61	-13.78	-12.75
EBITDA Margin	-162.78%	-382.28%	-483.31%	-3154.46%	-74695.52%
Depreciation & Amortization	0	0.03	0.04	0.03	0.03
EBIT	-4.13	-6.55	-5.65	-13.81	-12.78
EBIT Margin	-162.78%	-383.87%	-486.36%	-3161.06%	-74856.59%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).